-
-
-
-
-
-
-
VectivBio (VECT) Presents Preclinical Data Supporting Apraglutide for Treatment of Acute Graft-Versus-Host Disease at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantati
-
-
-
-
-
-
-
VectivBio Announces Closing of Comet Therapeutics Acquisition
-
-
-
-
-
-
-
VectivBio Holding AG (VECT) Acquires Comet Therapeutics; Will Host R&D Day
-
-
-
-
-
-
-
VectivBio Nominates Paul R. Carter and Murray W. Stewart for Election to its Board of Directors
-
-
-
14,665 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

